Trending Stories


From the latest healthcare headlines to MedAxiom community news, this is the place to learn more and stay informed. Updated regularly.

Cardiac imaging company Genetesis adds TDK Ventures as strategic investor

Partner News | Published: Wednesday, May 13, 2020

Genetesis Inc, a MedAxiom partner and medical technology company that has developed non-invasive, biomagnetic CardioFlux™ imaging, has announced several important updates. The company has closed

Keeping Your Patient Appointment Schedule Intact During (and After) the COVID-19 Pandemic

Partner News | Published: Monday, May 11, 2020

Medical practices are working through multiple issues brought on by the COVID-19 pandemic: supplying needed care for patients, uncertainties in staffing, PPE supply, PPP funding, and preserving revenue. Some

Farxiga approved in the US for the treatment of heart failure in patients with heart failure with reduced ejection fraction

Partner News | Published: Thursday, May 7, 2020

AstraZeneca’s Farxiga (dapagliflozin) has been approved in the US to reduce the risk of cardiovascular (CV) death and hospitalisation for heart failure in adults with heart failure (NYHA class II-IV)

A FAST, COMPREHENSIVE APPROACH FOR RE-OPENING YOUR CV SERVICE LINE

Partner News | Published: Monday, May 4, 2020

As we emerge from the unprecedented COVID-19 crisis, programs across the country are seeking a safe, rational approach to re-opening their Cath Labs and resuming elective revascularization. MedAxiom Industry

CMS Issues Second Interim-Final COVID-19 Rule

News | Published: Thursday, April 30, 2020

The Centers for Medicare and Medicaid Services (CMS) issued a second final-interim rule on April 30 that includes several key measures, including expanded access to COVID-19 testing and telehealth services.


TDK Ventures Invests in Biomagnetic Medical Imaging Company Genetesis

Partner News | Published: Wednesday, April 29, 2020

TDK Corporation (TSE:6762) announces that subsidiary TDK Ventures Inc. adds to its growing portfolio of companies with an investment in Genetesis, a world leader in non-invasive biomagnetic imaging. Genetesis

CARDIAC PET/CT MPI – Preparing your nuclear cardiac imaging lab during uncertain times

Partner News | Published: Wednesday, April 29, 2020

COVID-19, or the Coronavirus, has been the source of widespread concern across the country. This is a severe illness for those with a compromised immune system such as the elderly or those with preexisting

Physician-Hospital Alignment Still Eludes Many Integrated Programs

News | Published: Monday, April 27, 2020

Joel Sauer, Executive Vice President MedAxiom Consulting and Terri McDonald, Vice President MedAxiom Consulting authored this recently published Cardiac Interventions Today article explaining what has historically caused issues with physician-hospital integrations and provide ways to move toward transformational integration.


COVID-19 Relief Package Expands Upon CARES Act Resources

News | Published: Friday, April 24, 2020

The Paycheck Protection Program and Health Care Enhancement Act (H.R. 266) has been signed by President Trump into law after it passed in the House and Senate earlier this week, providing $484 billion for small businesses, health care providers and expanded testing to address the COVID-19 emergency. The package is widely considered an extension of the $2.2 trillion CARES Act, which passed in late March.


ENSURE YOUR EHR DATA IS ENGAGED CORRECTLY FOR TELEMEDICINE AND BEYOND

Partner News | Published: Thursday, April 23, 2020

COVID-19 is pushing the rapid adoption of virtual visits and telemedicine connectivity in order to treat both new and existing patients. It is vital that providers have historical health information for each